U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678177) titled 'An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients' on June 25.
Brief Summary: This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.
Study Start Date: March 07, 2023
Study Type: OBSERVATIONAL
Condition:
GERD (Gastroesophageal Reflux Disease)
Recruitment Status: RECRUITING
Sponsor: HK inno.N Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....